Ban Bossy
Ban Bossy is a public awareness campaign designed to encourage leadership in young girls by seeking to eliminate the negative connotations of the word "bossy." Launched in 2014, the campaign was initiated by Sheryl Sandberg, COO of Facebook, in partnership with the Girl Scouts of the USA and LeanIn.Org. The initiative has garnered support from various celebrities, educators, and organizations, aiming to challenge stereotypes and empower girls to pursue leadership roles without fear of criticism or being labeled as "bossy."
Background[edit]
The term "bossy" has often been used to describe assertive girls and women, carrying a negative implication that discourages females from taking leadership positions or speaking out. Research conducted by the Girl Scouts of the USA indicates that by middle school, more girls than boys believe that they are not suited for leadership roles. The Ban Bossy campaign argues that the label "bossy" is a significant barrier to girls' leadership and seeks to change the conversation around female leadership.
Campaign Goals[edit]
The primary goal of Ban Bossy is to empower young girls to lead by:
- Encouraging girls to embrace their leadership ambitions.
- Educating parents, teachers, and managers on the importance of encouraging girls to lead.
- Raising awareness about the negative impact of the word "bossy" and advocating for a change in the way society views female leadership.
Initiatives and Resources[edit]
Ban Bossy provides a range of resources and tools for different audiences, including:
- Leadership tips for girls.
- Guides for parents and educators on how to support girls' leadership.
- Public service announcements and videos featuring celebrities and leaders advocating for the campaign's message.
Criticism and Controversy[edit]
While Ban Bossy has received widespread support, it has also faced criticism. Some argue that the campaign focuses too narrowly on a single word rather than addressing the broader societal issues that discourage female leadership. Others believe that the campaign could inadvertently stigmatize the word "bossy" without providing a meaningful solution to the problem of gender inequality in leadership.
Impact[edit]
Despite the controversy, Ban Bossy has succeeded in sparking a global conversation about gender and leadership. It has encouraged educators, parents, and leaders across various sectors to reflect on their own biases and to actively support the leadership development of girls and young women.
See Also[edit]
This article is a social-movement-related stub. You can help WikiMD by expanding it!
-
Ban Bossy Logo
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian